Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders' Equity (Unaudited)

v3.24.1.u1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance (in shares) at Sep. 30, 2022   13,818,000                
Balance at Sep. 30, 2022   $ 138   $ 54,539   $ (1,898)   $ 94,803   $ 147,582
Stock-based compensation expense   $ 0   1,444   0   0   1,444
Issuance of common stock under equity compensation plans (in shares)   51,000                
Issuance of common stock under equity compensation plans   $ 1   954   0   0   954
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   10,000                
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (954)   0   0   (954)
Exercise of stock options, net of shares exchanged for payment (in shares)   10,000                
Exercise of stock options, net of shares exchanged for payment   $ 0   (471)   0   0   (471)
Other comprehensive income (loss)   0   0   1,665   0   1,665
Net (loss) income   $ 0   0   0   24,619   24,619
Issuance of common stock under employee stock purchase plan (in shares)   5,000                
Issuance of common stock under employee stock purchase plan   $ 0   299   0   0   299
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   (10,000)                
Issuance of common stock under employee stock purchase plan (in shares)   5,000                
Issuance of common stock under employee stock purchase plan   $ 0   299   0   0   299
Issuance of common stock, net (in shares)   1,380,000                
Issuance of common stock, net   $ 14   130,248   0   0   130,262
Balance (in shares) at Mar. 31, 2023   15,255,000                
Balance at Mar. 31, 2023   $ 153   186,058   (234)   119,422   305,399
Balance (in shares) at Dec. 31, 2022   15,218                
Balance at Dec. 31, 2022   $ 152   185,404   (733)   109,058   293,881
Stock-based compensation expense   $ 0   784   0   0   784
Issuance of common stock under equity compensation plans (in shares)   33,000                
Issuance of common stock under equity compensation plans   $ 1   0   0   0   1
Exercise of stock options, net of shares exchanged for payment (in shares)   3,000                
Exercise of stock options, net of shares exchanged for payment   $ 0   (130)   0   0   (130)
Other comprehensive income (loss)   0   0   499   0   499
Net (loss) income   $ 0   0   0   10,364   10,364
Balance (in shares) at Mar. 31, 2023   15,255,000                
Balance at Mar. 31, 2023   $ 153   186,058   (234)   119,422   305,399
Balance (in shares) at Dec. 31, 2022   15,218                
Balance at Dec. 31, 2022   $ 152   185,404   (733)   109,058   293,881
Balance (in shares) at Dec. 31, 2023   14,939,000                
Balance at Dec. 31, 2023   $ 149   177,322   476   122,148   300,095
Balance (in shares) at Sep. 30, 2023   15,255,000                
Balance at Sep. 30, 2023 $ 0 $ 153 $ 0 188,218 $ 0 (544) $ 80 127,336 $ 80 315,163
Stock-based compensation expense   $ 0   2,284   0   0   2,284
Issuance of common stock under equity compensation plans (in shares)   132,000                
Issuance of common stock under equity compensation plans   $ 1   (1)   0   0   0
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   9,000                
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (240)   0   0   (240)
Repurchase of common stock (in shares)   (979,000)                
Repurchase of common stock   $ (10)   (27,804)   0   0   (27,814)
Exercise of stock options, net of shares exchanged for payment (in shares)   1,000                
Exercise of stock options, net of shares exchanged for payment   $ 0   (9)   0   0   (9)
Other comprehensive income (loss)       0   674   0   674
Net (loss) income   $ 0   0   0   (11,179)   (11,179)
Issuance of common stock under employee stock purchase plan (in shares)   10,000                
Issuance of common stock under employee stock purchase plan   $ 0   250   0   0   250
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   (9,000)                
Issuance of common stock under employee stock purchase plan (in shares)   10,000                
Issuance of common stock under employee stock purchase plan   $ 0   250   0   0   250
Balance (in shares) at Mar. 31, 2024   14,410,000                
Balance at Mar. 31, 2024   $ 144   162,697   130   116,237   279,208
Balance (in shares) at Dec. 31, 2023   14,939,000                
Balance at Dec. 31, 2023   $ 149   177,322   476   122,148   300,095
Stock-based compensation expense   $ 0   1,012   0   0   1,012
Issuance of common stock under equity compensation plans (in shares)   14,000                
Issuance of common stock under equity compensation plans   $ 0   0   0   0   0
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   0                
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (4)   0   0   (4)
Repurchase of common stock (in shares)   (544,000)                
Repurchase of common stock   $ (5)   (15,624)   0   0   (15,629)
Exercise of stock options, net of shares exchanged for payment (in shares)   1,000                
Exercise of stock options, net of shares exchanged for payment   $ 0   (9)   0   0   (9)
Other comprehensive income (loss)   0   0   (346)   0   (346)
Net (loss) income   $ 0   0   0   (5,911)   (5,911)
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   0                
Balance (in shares) at Mar. 31, 2024   14,410,000                
Balance at Mar. 31, 2024   $ 144   $ 162,697   $ 130   $ 116,237   $ 279,208